Date published: 2025-11-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

Trav5n-4 Inhibitors

Trav5n-4 inhibitors are a distinct class of chemical compounds that target the Trav5n-4 protein or receptor, interfering with its biological activity through specific binding interactions. These inhibitors typically function by occupying the active site of Trav5n-4, preventing its natural substrates from binding and thus inhibiting the normal biochemical processes associated with this protein. In other cases, they may act as allosteric inhibitors, binding to regions of the protein that are separate from the active site but still inducing conformational changes that reduce its functional capacity. The binding interactions between Trav5n-4 inhibitors and the protein involve various types of non-covalent forces, such as hydrogen bonding, electrostatic interactions, hydrophobic contacts, and van der Waals forces, which collectively contribute to the stability and efficacy of the inhibitor-protein complex.

The structural diversity of Trav5n-4 inhibitors is a key aspect of their chemical nature. These inhibitors may range from small organic molecules to larger, more complex structures, depending on the specific design requirements. Common features include aromatic rings, heterocycles, and functional groups like hydroxyl, amine, or carboxyl groups, which enable them to establish strong interactions with the Trav5n-4 binding site. In designing these inhibitors, factors such as molecular weight, polarity, and flexibility are critical, as they influence both the binding affinity and specificity of the inhibitor for Trav5n-4. Additionally, the balance between hydrophilic and hydrophobic regions in the inhibitor is important for optimizing solubility and binding efficiency. These physicochemical properties, such as solubility, lipophilicity, and stability, are crucial for ensuring that the Trav5n-4 inhibitors maintain their structural integrity and binding capability in various biological environments, allowing for precise modulation of the Trav5n-4 protein's activity.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

Staurosporine is a potent inhibitor of protein kinases which might inhibit Trav5n-4 through reduction of phosphorylation events that are necessary for Trav5n-4 activity.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY294002 is a PI3K inhibitor that could reduce AKT activation, which may be necessary for Trav5n-4 function, leading to its inhibition.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

PD98059 is an inhibitor of MEK, which in turn could lead to reduced ERK activity, potentially inhibiting signaling pathways in which Trav5n-4 is involved.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 is a JNK inhibitor, potentially inhibiting JNK-mediated phosphorylation necessary for Trav5n-4’s function.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

SB203580 is a p38 MAPK inhibitor and may inhibit Trav5n-4 by disrupting MAPK pathway signaling necessary for its function.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Wortmannin is a PI3K inhibitor, which could inhibit AKT phosphorylation and downstream signaling required for Trav5n-4 activity.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Rapamycin inhibits mTOR, which could reduce the activity of downstream proteins that are essential for Trav5n-4 function.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

U0126 inhibits MEK1/2, potentially reducing ERK activation and signaling pathways involving Trav5n-4, leading to its inhibition.

ZM-447439

331771-20-1sc-200696
sc-200696A
1 mg
10 mg
$150.00
$349.00
15
(1)

ZM-447439 is an Aurora kinase inhibitor, potentially disrupting cell cycle progression and signaling that could be necessary for Trav5n-4 function.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$47.00
$145.00
51
(1)

Dasatinib is a Src family kinase inhibitor and may inhibit downstream signaling that could be essential for Trav5n-4’s activity.